GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor

In recent years mesenchymal stromal cells (MSCs) have received a great deal of interest for the treatment of major diseases, but clinical translation and market authorization have been slow. This has been due in part to a lack of standardization in cell manufacturing protocols, as well as a lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzgerald, Joan C., Duffy, Niamh, Cattaruzzi, Giacomo, Vitrani, Francesco, Paulitti, Alice, Mazzarol, Flavia, Mauro, Prisca, Sfiligoj, Antonio, Curcio, Francesco, Jones, Deirdre M., McInerney, Veronica, Krawczyk, Janusz, Kelly, Jack, Finnerty, Andrew, McDonagh, Katya, McCabe, Una, Duggan, Matthew, Connolly, Lauren, Shaw, Georgina, Murphy, Mary, Barry, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959900/
https://www.ncbi.nlm.nih.gov/pubmed/35356775
http://dx.doi.org/10.3389/fbioe.2022.834267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959900/
https://www.ncbi.nlm.nih.gov/pubmed/35356775
http://dx.doi.org/10.3389/fbioe.2022.834267

Ejemplares similares